Skip to content
Home/Companies/Life Science Tools & Biologic Services/PlasmidFactory
PlasmidFactory

PlasmidFactory

Life Science Tools & Biologic Services·Germany·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns PlasmidFactory?

PlasmidFactory is currently owned by ARCHIMED through MED III (2021 vintage), since 2022.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED III · 2021 · Buyout

Key facts

HQGermany
SectorLife Science Tools & Biologic Services
Websitewww.plasmidfactory.com

More from MED III

Other portfolio companies in the same fund.

BioVendor Group
Active
MedTechCzech Republic· 2025
DermaPharm
DermaPharm
Active
HealthTechDenmark· 2025
Natus Sensory
Natus Sensory
Active
MedTechUS· 2022
Title21 Health Solutions
Title21 Health Solutions
Active
HealthTechUS· 2022
Aliri
Aliri
Active
PharmaUS· 2021
Cardioline
Cardioline
Active
MedTechItaly· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track PlasmidFactory

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy PlasmidFactory?

8 strategic and 112financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on PlasmidFactory.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue